Epstein Secrets

From: "Ens, Amanda" •fl• To: "jeevacationtantail.com" <[email protected]> Cc: Richard Kahn Subject: Prefermds, thoughts on fixed income, mandatory converts Date: Thu, 04 Aug 2016 22:30:04 +0000 Attachments: GEVI_6.28.2016.pdf: AGN.PDF: T

tantail.com" <[email protected]> Cc: Richard Kahn Subject: Prefermds, thoughts on fixed income, ma

ue to its healthy product mix, solid pipeline and flexibility to deploy capital to drive shareholder return. Next catalyst will be 2Q earnings/V.116 Outlook on 8/8. AGN Is on our firm's US-1 list of best investment Ideas. Teva Pharma (TWA) - BAML reiterating BUY on TEVA after the FTCs approval of AGN gen

From: Richard Kahn To: "Jeffrey E" <[email protected]> Subject: Fwd: The ECB Loosened Policy Aggressively, Supporting our Eurozone Outlook and Portfolio Positionin

From: Richard Kahn To: "Jeffrey E" <[email protected]> Subject:

These measures should lower the cost of funding for banks and corporates, and support a gradual economic recovery in the Eurozone, in line with our Outlook. • The ECB lowered its benchmark interest rates (main refinancing rate: -5bp to 0%; deposit facility rate: -10bp to -0.4%). • The ECB increased th

Mobile: The power of global connectionsTM 7- 7.1114 From: Ens, Amanda Sent: Thursday, August 04, 2016 6:30 PM To: ijeevacatiorOgmail.comi Cc: 'Richard Kahn' Subject: Preferreds, thoughts on fixed income, mandatory converts Jeffrey, Rich mentioned you're interested in potentially buying preferreds. Whil

o: "Jeffrey E." <[email protected]>, Richard Kahn imacie001.0nq image002.1pg imacte003.i0q imac

due to its healthy product mix, solid pipeline and flexibility to deploy capital to drive shareholder return. Next catalyst will be 2Q earnings/2H16 Outlook on 8/8. AGN is on our firm's US-1 list of best investment ideas. Teva Pharma (TEVA) - BAML reiterating BUY on TEVA after the FTC's approval of AGN

global co=nections'm EFTA_R1_01556242 EFTA02454468 From: Ens, Ama=da Sent: Thursday, August 04, 2016 6:30 PM To: '[email protected]' Cc: 'Richard Kahn' Subject: Preferreds, thoughts on fixed income, mandatory converts Jeffre=, Rich m=ntioned you're interested in potentially buying preferreds. Whil

6:26 PM To: [email protected] Cc: Richard Kahn Subject: RE: Preferreds, thoughts on fixed inco

ue to its healthy product mix, solid pipe=ine and flexibility to deploy capital to drive shareholder return. N=xt catalyst will be 2Q earnings/2H16 Outlook on 8/8. AGN is on our firm :=17;s US-1 list of best investment ideas. Teva Pharma (TEVA) - BAML reiterating BUY on TEVA after the FTC's approval=of

com <[email protected]> ' Cc: 'Richard Kahn' Subject: Preferreds, thoughts on fixed income,

of global connections'" From: Ens, Amanda Sent: Thursday, August 04, 2016 6:30 PM To:'[email protected] <[email protected]> ' Cc: 'Richard Kahn' Subject: Preferreds, thoughts on fixed income, mandatory converts Jeffrey, Rich mentioned you're interested in potentially buying preferreds. Whil

ue to its healthy product mix, solid pipeline and flexibility to deploy capital to drive shareholder return. Next catalyst will be 2Q earnings/2H16 Outlook on 8/8. AGN is on our firm's US-1 list of best investment ideas. Teva Pharma (TEVA) - BAML reiterating BUY on TEVA after the FTC's approval of AGN g

f global connections'" From: Ens, Amanda Sent: Thursday, August 04, 2016 6:30 PM To: '[email protected] <mailto:[email protected]> ' Cc: 'Richard Kahn' Subject: Preferreds, thoughts on fixed income, mandatory converts Jeffrey, Rich mentioned you're interested in potentially buying preferreds. Whil

om <mailto:[email protected]> ' Cc: 'Richard Kahn' Subject: Preferreds, thoughts on fixed income,

ue to its healthy product mix, solid pipeline and flexibility to deploy capital to drive shareholder return. Next catalyst will be 2Q earnings/2H16 Outlook on 8/8. AGN is on our firm's US-1 list of best investment ideas. Teva Pharma (TEVA) - BAML reiterating BUY on TEVA after the FTC's approval of AGN g

f global connections'" From: Ens, Amanda Sent: Thursday, August 04, 2016 6:30 PM To: '[email protected] <mailto:[email protected]> ' Cc: 'Richard Kahn' Subject: Preferreds, thoughts on fixed income, mandatory converts Jeffrey, Rich mentioned you're interested in potentially buying preferreds. Whil

om <mailto:[email protected]> ' Cc: 'Richard Kahn' Subject: Preferreds, thoughts on fixed income,

ue to its healthy product mix, solid pipeline and flexibility to deploy capital to drive shareholder return. Next catalyst will be 2Q earnings/2H16 Outlook on 8/8. AGN is on our firm's US-1 list of best investment ideas. Teva Pharma (TEVA) - BAML reiterating BUY on TEVA after the FTC's approval of AGN g

REPORTING COMPANY www.veritext.com EFTA00299205 Page 122 1 Epstein 2 negligence and a fiduciary obligation of Perry 3 Gruss, Dan Zwirn, Mr. Kahn, whoever I'm 4 unfamiliar with his first name -- that no one made 5 disclosure to me at any relevant time so that each 11:41:21 6 one had brea

e-mail with -- when you reply to an e-mail 18 with attachments, the attachments don't go. 19 When they're forwarded, they do go. That's 20 how Outlook and most systems work. 02:46:13 21 A. Okay. 22 Q. There's no sir, just go back to 23 Exhibit 8 so we can be clear. On Exhibit 8 the 24 e-